Dr. Margaret Chen is conducting the MammaPrint study looking at genetic biomarkers among Chinese women with early stage breast cancer in the US and Hong Kong.
Researchers at NYP/Columbia have recently launched an important trial of immunotherapy plus chemotherapy as neoadjuvant therapy for patients with locally advanced non-small cell lung cancer (NSCLC).